Induction of S Phase Arrest and Apoptosis by Ethyl Acetate Extract from Tetrastigma Hemsleyanum in Human Hepatoma HepG2 Cells

Xin Peng,Ding-ding Zhuang,Qiao-sheng Guo

DOI: https://doi.org/10.1007/s13277-014-2869-x

2015-01-01

Tumor Biology

Abstract:Tetrastigma hemsleyanum , a rare and endangered medicinal plant, has attracted much attention due to antitumor and immunomodulatory activities. In this study, the effect and mechanism of ethyl acetate extract from T. hemsleyanum (EET) on cell cycle and apoptosis in human hepatoma HepG 2 cells were investigated. Twenty-five to 200 μg/mL of EET were found to have the antiproliferation effect toward HepG 2 cells determined by MTT assay. The morphology of EET-treated HepG 2 cells showed evidence of apoptosis that included blebbing and chromatin condensation, nucleic fragmentation, and so on. The DNA laddering assay confirmed that DNA fragmentation had occurred during late apoptosis. The cell-cycle analysis indicated that EET was able to induce S phase arrest and typical subdiploid peak in a dose- and time-dependent manner. The apoptosis rate of 200 μg/mL treatment for 24 h was 42.24 ± 4.90 %. The protein expression of Bax and P53 was increased after treatment, while that of Bcl 2 was significantly decreased in a dose-dependent manner, which suggested that a high Bax/Bcl 2 ratio and an upregulated P53 might contribute to the pro-apoptotic activity of EET via the mitochondria-dependent pathway. The protein expression of cyclin-dependent kinase 1 (CDK 1 ) was decreased in EET-treated HepG 2 cells, suggesting that EET evoked S phase arrest possibly through the downregulation of cyclin A-CDK 1 complex. In conclusion, the cytotoxicity on HepG 2 cells induced by EET is a result of both cell-cycle arrest and apoptosis. Thus, it may have therapeutic potential for the treatment of liver cancer.